Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H27NO5S2 |
InChIKeyDQVRUUKJUZNKSW-UHFFFAOYSA-N |
CAS Registry2595314-46-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | AU | 07 Oct 2019 |